Congratulations to Dr. Ami Patel for her selection in the VPCAT Research Scholars Program
RECOGNITION
Nov 27, 2018

Congratulations to Dr. Ami Patel for her selection in the VPCAT Research Scholars Program

Congratulations to Dr. Ami Patel for her selection in the VPCAT Research Scholars Program at the University of Utah. This is a two-year program providing scholars with mentoring and leadership training and research resources. Selected scholars have access to biostatisticians in the Center for Clinical & Translational Science (CCTS) and grant submission specialists. These resources facilitate appropriate study design, collection of pilot data and the preparation and submission of competitive grant applications.... Read More

Welcome Dr. Ming Lim
RECOGNITION
Nov 01, 2018

Welcome Dr. Ming Lim

Dr. Ming Lim is joining the Hematology/Hematologic Malignancies department specializing in non-malignant hematology. She earned her medical degree at Cambridge University, England and completed her 2-year Foundation Training in the United Kingdom. She then completed residency in internal medicine at the Mayo Clinic Rochester and fellowship training in hematology and oncology at University of North Carolina at Chapel Hill. Her main interests lies in the field of hemostasis and thrombosis. Her research interest is focused on complications affecting patients with congenital bleeding disorders, specifically hemophilia patients with inhibitors. Previously, Dr. Lim was Assistant Professor of Medicine in the Division of Hematology/Oncology at the Medical University of South Carolina from 2015-2018. There she also served as the Associate Program Director for the MUSC Hematology/Oncology Fellowship Program. Dr. Lim is actively involved in the American Society of Hematology (ASH) and the Hemostasis and Thrombosis Research Society (HTRS). She serves as the Co-Chair for the HTRS Junior Faculty Network and is a committee member for the HTRS Trainee Workshop.... Read More

Celebrating Advanced Practice Clinicians
RECOGNITION
Oct 23, 2018

Celebrating Advanced Practice Clinicians

Natalie Turner, AGACNP (Hematology) is one of many great APCs working for The Department of Internal Medicine. We are recognizing them for the exceptional care they provide to our patients.... Read More

Congratulations Dr. Dennis Winge
RECOGNITION, RESEARCH
Oct 01, 2018

Congratulations Dr. Dennis Winge

Congratulations to Dr. Dennis Winge who was awarded a R01 Competitive Renewal Grant from the NIH National Institute of General Medical Sciences.... Read More

HemOnc Today honors Next Gen Innovators at ASCO
RECOGNITION
Sep 25, 2018

HemOnc Today honors Next Gen Innovators at ASCO

Congratulations Deborah M. Stephens, DO (Hematology), Ignacio Garrido-Laguna, MD, and Ben Maughan, MD (Oncology) on being recognized as Next Gen Innovators, which is an initiative that helps showcase the talents and expertise of rising stars in hematology and oncology. Read More.... Read More

Welcome Dr. Boyu Hu
RECOGNITION
Sep 01, 2018

Welcome Dr. Boyu Hu

Dr. Boyu Hu is joining the Hematology/Hematologic Malignancies department specializing in lymphoma, chronic lymphocytic leukemia and lymphoma genetics and prognostication. ... Read More

Hematology Research Symposium at Deer Valley
EDUCATION
May 22, 2018

Hematology Research Symposium at Deer Valley

The Hematology Research Symposium on June 8-9, 2018 will feature a host of internal and external experts promoting the many strengths of hematologic research including lymphoid and myeloid malignancies, immunotherapy, genomics in hematologic malignancies, and more. ... Read More

Dr. Paul Bray Recipient of NIH Grant
RESEARCH
Apr 20, 2018

Dr. Paul Bray Recipient of NIH Grant

Congratulations to Dr. Paul Bray for his award of a NIH grant from the National Heart, Lung, and Blood Institute. The grant awarded from 2018 through 2022 is focused on in vivo studies of megakaryocyte microRNAs regulating platelet number and integrin activation. The goal of Dr. Bray’s studies is to glean insights into the molecular genetic mechanisms that contribute to blood platelet formation and function. Dr. Bray and his team will investigate the role of microRNA regulation of megakaryocyte gene expression and test the hypothesis that specific microRNAs modulate the development of megakaryocytes into platelets and platelet function. One additional aspect of their studies will be testing whether microRNAs can enhance the in vitro production of platelets as a potential therapeutic for thrombocytopenia and thrombocytosis.... Read More

CAR T-Cell Lymphoma Trial Underway
RESEARCH
Apr 02, 2018

CAR T-Cell Lymphoma Trial Underway

The University of Utah and Huntsman Cancer Institute were just selected as one of the few national cancer centers for a large Novartis and KITE Pharma Inc.-sponsored anti-CD19 CAR T-cell immunotherapy clinical trial focused on relapsed or refractory diffuse large B-cell lymphoma, a form of non-Hodgkin lymphoma. Our Cell Therapy and Regenerative Medicine Program (CTRM) Center will be a key component of this clinical trial. The FDA requires special certification for sites offering CAR T-cell therapy, and only specially trained hospitals and clinics are part of the network of treatment centers.This is an exciting new immunotherapy option for lymphoma patients.... Read More

EDUCATION
Apr 02, 2018

Alternative Transportation Incentive Program

Nearly a year ago, Dr. Deininger and the Division of Hematology Administration announced a Division Commuter Incentive Program to encourage faculty and staff to take alternative modes of transportation to work apart from vehicle driving. The goals were to promote employee health and make our contribution to lowering our carbon footprint. Seventeen Division employees completed the survey to participate and in the course of this past year, the group of participants amassed a grand total of 22,496 miles of alternative commuting (UTA bus/train, walking & cycling). Included in the Incentive Program was a drawing held monthly to select monthly commuter winners and three grand prize awardees who amassed the most number of trips over the year. The number of monthly commuter trips has held quite constant during the past year among participants. The goal is now to expand the number of participants and to model this to a larger Health Sciences Program. ... Read More

3rd Annual HCI Immunotherapy Conference
EDUCATION, RESEARCH
Mar 28, 2018

3rd Annual HCI Immunotherapy Conference

The third annual Huntsman Cancer Institute Cancer Immunotherapy Conference will be held on April 27, 2018 in the J. Willard and Alice S. Marriott Foundation Auditorium in the HCI Research South Building starting at 7:45 AM. The conference will include basic scientists and clinicians with an interest in immunotheraphies for cancer treatment. Among the speakers are Kevin Hay, MD; Annette Künkele, MD; Chris DeRenzo, MD, MBA; and Yong-Chen William Lu, Ph.D.... Read More

HCI Joins Study Aimed at Improving Leukemia Screening, Treatment
RESEARCH
Mar 28, 2018

HCI Joins Study Aimed at Improving Leukemia Screening, Treatment

A new clinical trial for patients with acute myeloid leukemia will open at the Huntsman Cancer Institute. This trial consisting of eight academic centers will conduct a quick molecular genetic test to guide physicians in the appropriate treatment. This personalized treatment protocol should enhance the effectiveness in AML therapy. The trial seeks to enroll 500 subjects and is estimated to be completed in 2021. Dr. Mike Deininger, Dr. Tibor Kovacsovics and Dr. Paul Shami will lead the clinical trial at the Huntsman Cancer Institute.... Read More

Congratulations Dr. Luetkens
RESEARCH, RECOGNITION
Mar 20, 2018

Congratulations Dr. Luetkens

The National Comprehensive Cancer Network (NCCN) Foundation announced Dr. Tim Luetkens in the Division of Hematology and Hematologic Malignancies as a recipient of the 2018 Young Investigator Awards. The NCCN Foundation selects 4 young investigators at the forefront of their field each year to support their career development. These highly qualified researchers are noted for their innovative ideas in improving the quality, effectiveness, and efficiency of care provided to cancer patients. Dr. Luetkens’ innovative research in the laboratory of Professor Djordje Atanackovic focuses on CD229 CAR T cell immunotherapy in Multiple Myeloma. Dr. Luetkens will be awarded $150,000 over a two-year period to support his innovative work.... Read More

Congratulations Dr. Shami
RECOGNITION
Mar 12, 2018

Congratulations Dr. Shami

Congratulations to Dr. Paul Shami on his appointment as Research Compliance Office Medical Director. Dr. Shami will also chair the Data and Safety Monitoring Committee and will provide leadership to the Research Compliance Office in ensuring safe, ethical, and responsible conduct of clinical research at HCI.... Read More

Archives by Year